EMPLOYMENT AGREEMENTEmployment Agreement • April 1st, 2008 • Virexx Medical Corp • Biological products, (no disgnostic substances) • Alberta
NOW THEREFORE THIS AGREEMENT WITNESSES that in consideration of the mutual covenants and agreements referred to herein, and the sum of TEN DOLLARS ($10) now paid or to be paid on behalf of the Employer to the Employee, the receipt and sufficiency of which consideration is hereby acknowledged, the parties covenant and agree as follows:
EMPLOYMENT AGREEMENTEmployment Agreement • April 1st, 2008 • Virexx Medical Corp • Biological products, (no disgnostic substances) • Alberta
WHEREAS ViRexx carries on the business of a biopharmaceutical company focused on developing and commercializing therapeutic products for the treatment of chronic hepatitis B, hepatitis C and selected solid tumors (hereinafter called the “Business”);
CONSULTING SERVICES AGREEMENTConsulting Services Agreement • April 1st, 2008 • Virexx Medical Corp • Biological products, (no disgnostic substances) • Alberta
NOW THEREFORE THIS AGREEMENT WITNESSES that in consideration of the foregoing recitals and of the mutual promises, covenants and agreements hereinafter set forth, the Company and the Contractor hereby promise, covenant and agree as follows:
CONSULTING SERVICES AGREEMENTConsulting Services Agreement • April 1st, 2008 • Virexx Medical Corp • Biological products, (no disgnostic substances)
CONSULTING SERVICES AGREEMENTConsulting Services Agreement • April 1st, 2008 • Virexx Medical Corp • Biological products, (no disgnostic substances) • Alberta
WHEREAS ViRexx carries on the business of a biopharmaceutical company focused on developing and commercializing immunal therapeutic products and products for the treatment of selected solid tumors and fibroids (hereinafter called the “Business”), and is developing particular products, specifically, OvaRex MAb, Occlusin 50 Injection and Occlusin 500 AED (the ”ViRexx Products”)
VIREXX MEDICAL CORP.Interim Management Agreement • April 1st, 2008 • Virexx Medical Corp • Biological products, (no disgnostic substances)
This letter agreement confirms that ViRexx Medical Corp. (“ViRexx”) hereby agrees that Gemini shall be engaged to provide the services of Erich Bam, as Interim Chief Operating Officer of ViRexx on the following terms and conditions:
